PCSK9 Inhibition, Atherosclerotic Cardiovascular Disease and Health Economics: Challenges at the Crossroads

Journal of Clinical Lipidology- Netherlands

doi 10.1016/j.jacl.2019.07.005

Full Text

Abstract

Available in

Categories

Internal Medicine

Cardiovascular Medicine

Date

September 1, 2019

Authors

Lieven Annemans

M. John Chapman

Publisher

Elsevier BV

Related search

Stress and Atherosclerotic Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis

Internal Medicine

Cardiovascular Medicine

English

Public Health and Medicine at the Crossroads

Public Health Reports (1896-1970)

English

Antibiotic Treatment of Atherosclerotic Cardiovascular Disease

Cardiovascular Medicine

English

Bodies at the Crossroads Between Immigration and Health

Global Perspectives on Health Geography

English

SIRT1 and Gender Differences in Atherosclerotic Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis

Internal Medicine

Cardiovascular Medicine

English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

English

Whole Grains Protect Against Atherosclerotic Cardiovascular Disease

Proceedings of the Nutrition Society

English

PCSK9 as Predictor for Recurrent Cardiovascular Disease in Familial Hypercholesterolemia

European Journal of Preventive Cardiology

Cardiovascular Medicine

English

Atherosclerotic Cardiovascular Disease in Older Adults With Diabetes Mellitus

Clinics in Geriatric Medicine

English